Spin-off Archives - Institute for Bioengineering of Catalonia

February 13, 2025December 18, 2024

LUMIRIS, the IBEC spin-off that has raised €6 million to transform assisted reproduction

This spin-off from the Institute for Bioengineering of Catalonia has developed a non-invasive technology that analyses the metabolism of human embryos to select the most suitable ones for implantation. This innovation promises to significantly reduce the time and number of treatment cycles required for in vitro fertilisation. The success of LUMIRIS’ technology has led to a new round of investment of €1.5 million, bringing the total to €6 million since the company was founded in 2023.

February 14, 2025December 12, 2024

IBEC and SJD Barcelona Children’s Hospital strengthen their collaboration with a day of translational innovation

The Institute for Bioengineering of Catalonia and the Sant Joan de Déu Barcelona Children’s Hospital have held a joint conference to strengthen collaboration in bioengineering and translational medicine. The event, held this morning at the IBEC, highlighted innovative projects, presented a joint PhD programme and encouraged the exchange of ideas between researchers from both institutions.

February 20, 2025December 2, 2024

EXPANSIÓN: Nanobots capta casi un millón de euros en una ronda semilla

La start-up catalana Nanobots Therapeutics, una spin-off del Instituto de Bioingeniería de Catalunya, ha captado 960.000 euros de capital privado.

February 14, 2025November 22, 2024

IBEC and VHIR hold a collaboration day to promote synergies

The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.

February 14, 2025November 1, 2024

IBEC and BST strengthen ties with Translational Collaboration Day

IBEC and the Blood and Tissue Bank of Catalonia (BST) held a day to explore new collaborations in bioengineering and translational medicine. The meeting, held yesterday at IBEC, highlighted innovative projects, presented a joint PhD programme and strengthened the link between biomedical research and clinical applications.

November 30, 2023November 30, 2023

IBEC engages in two public-private partnerships for biomedical breakthroughs

IBEC and Vitala, a spin-off founded by IBEC researchers, are set to participate in three public-private partnership projects, with a combined investment nearing €4 million. These initiatives, backed by the Spanish Ministry of Science and Innovation and the State Research Agency, aim to advance remote health monitoring, create an oral drug for Inflammatory Bowel Disease, and enhance 13C magnetic resonance imaging for therapeutic research. Leveraging cutting-edge technological approaches, these endeavors aspire to make a positive impact on the fields of medicine and biomedical research.

September 22, 2023

Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000

The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in … Read more

May 5, 2023

Vitala, IBEC’s spin-off, selected for the WomenTechEU programme

Vitala, a spin-off co-founded by IBEC researchers Irene Marco Rius and María Alejandra Ortega, is one of the 134 European companies selected for the WomenTechEU program. It is an initiative … Read more

February 28, 2023February 27, 2023

IBEC and ICREA launch the spin-off Nanobots Therapeutics to develop a new nanotherapy modality in the field of oncology

Nanobots Therapeutics is the spin-off recently created by the Institute of Bioengineering of Catalonia (IBEC) and the Catalan Institution for Research and Advanced Studies (ICREA) that proposes to develop a … Read more

October 9, 2019September 27, 2019

Rob Surgical, the spin-off created by IBEC and the UPC, closes a €5 million investment round with Scranton Enterprises

Rob Surgical, the spin-off created by the Institute for Bioengineering of Catalonia (IBEC) and the Polytechnic University of Catalonia (UPC) in 2012, has closed a €5 million investment round with the Dutch holding Scranton Enterprises to fund the final phase of the new Bitrack System and launch the product onto the market

Rob Surgical is a company which designs and develops new robotic systems for minimally invasive surgery. The investment will facilitate the obtention of the CE marking for the new Bitrack System, which will enable it’s break into the market to improve the effectiveness of current surgical robotics.

The Bitrack System will be an alternative to the current laparoscopy surgical robot Da Vinci and will be an improvement on what is currently available in terms of efficiency.